BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7229372)

  • 21. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):575-82. PubMed ID: 4536807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the alternative pathway by pneumococcal cell walls.
    Winkelstein JA; Tomasz A
    J Immunol; 1977 Feb; 118(2):451-4. PubMed ID: 14211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae.
    Edwards KM; Gewurz H; Lint TF; Mold C
    J Immunol; 1982 Jun; 128(6):2493-6. PubMed ID: 7077077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood clearance of Streptococcus pneumoniae by C-reactive protein.
    Horowitz J; Volanakis JE; Briles DE
    J Immunol; 1987 Apr; 138(8):2598-603. PubMed ID: 3559209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of opsonins in recovery from experimental pneumococcal pneumonia.
    Guckian JC; Christensen GD; Fine DP
    J Infect Dis; 1980 Aug; 142(2):175-90. PubMed ID: 6997403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of red blood cell stroma on the reticuloendothelial system clearance and killing of Streptococcus pneumoniae.
    Grover GJ; Loegering DJ
    Circ Shock; 1984; 14(1):39-47. PubMed ID: 6488481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classical pathway of complement activation in mammalian kidneys.
    Zwirner J; Felber E; Burger R; Bitter-Suermann D; Riethmüller G; Feucht HE
    Immunology; 1993 Oct; 80(2):162-7. PubMed ID: 8262545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages.
    Daha MR; Van Es LA
    Immunology; 1981 Jul; 43(3):513-8. PubMed ID: 7251062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced susceptibility of mice with streptozotocin-induced diabetes to type II group B streptococcal infection.
    Edwards MS; Fuselier PA
    Infect Immun; 1983 Feb; 39(2):580-5. PubMed ID: 6339383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the alternative complement pathway by natural antibody to glycolipids in guinea-pig serum.
    Okada N; Yasuda T; Tsumita T; Okada H
    Immunology; 1983 Sep; 50(1):75-84. PubMed ID: 6193057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species variation in the mechanism of killing of inhaled pneumococci.
    Coonrod JD; Varble R; Jarrells MC
    J Lab Clin Med; 1990 Sep; 116(3):354-62. PubMed ID: 2401849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pig to canine auxiliary hepatic xenotransplantation model: prevention of hyperacute rejection via Kupffer cell blockade and complement regulation.
    Chung KY; Park JJ; Han KH
    Transplant Proc; 2008 Oct; 40(8):2755-9. PubMed ID: 18929854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opsonization of pneumococci. II. Metabolic effects of a "third" human serum activity that mediates intracellular killing.
    Guckian JC; Cavallo T; Fine DP
    J Immunol; 1981 Oct; 127(4):1666-70. PubMed ID: 7276578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5.
    Shin HS; Smith MR; Wood WB
    J Exp Med; 1969 Dec; 130(6):1229-41. PubMed ID: 4390900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of antibody upon clearance of I-125-labelled pneumococci by the spleen and liver.
    Schulkind ML; Ellis EF; Smith RT
    Pediatr Res; 1967 May; 1(3):178-84. PubMed ID: 4384049
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased susceptibility to infection in sickle cell disease: defects of opsonization and of splenic function.
    Johnston RB; Newman SL; Struth AG
    Birth Defects Orig Artic Ser; 1975; 11(1):322-7. PubMed ID: 238677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired resistance to ticks: expression of resistance by C4-deficient guinea pigs.
    Wikel SK
    Am J Trop Med Hyg; 1979 May; 28(3):586-90. PubMed ID: 453452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced degradation of soluble immunoglobulin aggregates by macrophages in the presence of complement.
    Kijlstra A; Van Es LA; Daha MR
    Immunology; 1979 Jul; 37(3):673-80. PubMed ID: 500123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
    Regal JF; Fraser DG; Toth CA
    J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bactericidal and opsonic properties of C4-deficient guinea pig serum.
    Root RK; Ellman L; Frank MM
    J Immunol; 1972 Sep; 109(3):477-86. PubMed ID: 4403402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.